Fullife Healthcare, the parent company of the Fast&Up and Chicnutrix brands, plans to reach ₹1,000 crore in revenue within five years. After significantly narrowing its net losses in FY25, the company is utilizing fresh capital to expand its footprint from sports nutrition into the broader mainstream wellness market.
Fullife Healthcare, the parent company behind nutrition brands Fast&Up and Chicnutrix, has outlined a strategic roadmap to grow its revenue to ₹1,000 crore over the next five years. The company is pivoting from its original focus on sports nutrition and elite athletes toward a wider consumer base, aiming to capture demand in the broader health and wellness segment.
Financial Performance and Growth
The company’s push for scale comes against the backdrop of an improving financial performance. In the 2025 fiscal year (FY25), Fullife Healthcare reported revenue of nearly ₹250 crore, marking a steady increase from ₹195.1 crore in the previous year. Alongside revenue growth, the company has also demonstrated a move toward financial discipline, narrowing its net loss to ₹13.4 crore in FY25, down from a loss of ₹30.2 crore in FY24. This trend of rising income combined with reduced losses is a key metric the company is focusing on as it attempts to balance expansion with sustainable profitability.
In March 2026, the company successfully raised ₹300 crore in a Series D funding round led by Elev8 Venture Partners. This infusion of capital is expected to support the company’s efforts to scale its operations, invest in new product development, and strengthen its international presence.
Strategic Expansion Beyond Sports
Initially known for its effervescent sports nutrition products under the Fast&Up label, the company has diversified its portfolio to include active nutrition, hydration, and energy products. Additionally, it has expanded into beauty nutrition through the Chicnutrix brand, which offers supplements targeted at skin, hair, and nail health.
This product diversification is part of a larger plan to establish a global wellness footprint. The company has prioritized expansion into markets such as the UK, Europe, and the GCC region. By moving manufacturing technology from Switzerland to India for in-house production, Fullife aims to maintain control over quality and reduce costs, providing it with a competitive edge over imported or outsourced alternatives.
Challenges in the Wellness Sector
While the expansion plans are ambitious, Fullife Healthcare operates in a highly crowded and competitive sector. The wellness and nutrition market in India is home to both large multinational corporations and a growing number of digital-native startups, all vying for the health-conscious consumer.
For investors and stakeholders, the primary monitorables will be how effectively the company executes its international expansion and whether it can maintain its trend of reducing losses while managing the costs associated with scaling. Entering new categories—such as digestive or sleep health—often requires high marketing and customer acquisition spending, which could pressure profit margins in the short term. Additionally, shifting consumer preferences and the complexities of navigating different regulatory environments in international markets remain key operational risks that could impact the company’s ability to meet its long-term revenue targets.